Conditions: Infection, Human Immunodeficiency Virus I
Keywords: HIV-1 GW873140 CCR5 antagonist experienced
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 24
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety and efficacy of the CCR5 antagonist GW873140 or placebo in combination with an optimized background regimen in treatment-experienced HIV-infected subjects with R5-tropic virus

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: GW873140
Intervention descriptions: intervention 1: 400 mg twice daily

Protocol document: